SCHEMBL1849100

SCHEMBL1849100

CC(CCN)Nc1ncc(C(N)=O)c(Nc2cccc(-c3ncccn3)c2)n1

nearest known ligand 0.86

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SYK P43405 20/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1849098 1.00 SYK (0.86) SYK
SCHEMBL1354473 0.93 SYK (1.00) SYK
SCHEMBL1354470 0.93 SYK (1.00) SYK
SCHEMBL1847949 0.89 SYK (0.86) SYK
SCHEMBL1847087 0.87 SYK (0.83) SYK
SCHEMBL1353980 0.87 SYK (1.00) SYK
SCHEMBL1353977 0.87 SYK (1.00) SYK
SCHEMBL1354403 0.85 SYK (0.83) SYK
SCHEMBL1354405 0.85 SYK (0.83) SYK
SCHEMBL2716760 0.85 SYK (0.63) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323993-A2 2,6-DIAMINO- PYRIMIDIN- 5-YL-CARBOXAMIDES AS SYK OR JAK KINASES INHIBITORS Portola Pharmaceuticals, Inc. (US) 2011-05-25 EP disclosed
WO-2009136995-A2 INHIBITORS OF SYK PROTEIN KINASE PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-12 WO disclosed